bioAffinity Technologies, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q3 2023 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
bioAffinity Technologies, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q3 2023 to Q3 2024.
  • bioAffinity Technologies, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $494K, a 25.8% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $494K +$101K +25.8% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $325K Jun 30, 2024 10-Q 2024-08-14
Q1 2024 $348K Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $370K Dec 31, 2023 10-Q 2024-11-14
Q3 2023 $392K Sep 30, 2023 10-Q 2023-11-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.